Correction to: BMC Ophthalmol (2019) 19:131
https://doi.org/10.1186/s12886-019-1136-8
The editor has retracted this article [1]. In the accompanying trial registry [2] the authors stated that they conducted three separate arms of this clinical trial. The article only reports the results of two of the arms. The data and the results of this article are therefore unreliable. Additionally, there is considerable overlap with a previously published article by the same authors [3].
**All authors agree to this retraction
Reference
Park, et al. Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial. BMC. Ophthalmol. 2019;19:131. https://doi.org/10.1186/s12886-019-1136-8.
https://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=6936.
Park CH, Kim MK, Kim EC, Kim JY, Kim TI, Kim HK, Song JS, Yoon KC, Lee DH, Lee HK, Chung TY, Choi CY, Kim HS. Efficacy of Topical Cyclosporine Nanoemulsion 0.05% Compared with Topical Cyclosporine Emulsion 0.05% and Diquafosol 3% in Dry Eye. Korean J Ophthalmol. 2019;33(4):343–52. https://doi.org/10.3341/kjo.2018.0116.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Park, C.H., Lee, H.K., Kim, M.K. et al. Retraction Note: Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial. BMC Ophthalmol 20, 251 (2020). https://doi.org/10.1186/s12886-020-01524-8
Published:
DOI: https://doi.org/10.1186/s12886-020-01524-8